FDA Would Get Less Funding, Different Inspection Priorities Under Senate Legislation Than House
Executive Summary
CDER would lose the most money in the Senate appropriations bill compared to the House version, while CBER would see an increase.
You may also be interested in...
Appropriators Continue Pressing US FDA To Conduct Surprise In-Person Inspections
Omnibus package also gives FDA expanded authority over nicotine products and creates President Biden’s Advanced Research Projects Agency for Health.
House Appropriators Continue Pressing US FDA To Conduct Surprise In-Person Inspections
The bill also would give the FDA expanded authority over nicotine products and create President Biden’s Advanced Research Projects Agency for Health.
Remote Inspections: Stakeholders Seek Clarity As Some At US FDA Struggle With Process
Some lawmakers want FDA to prioritize in-person visits, but others are complaining that more remote inspections are needed because approvals are being delayed.